Cargando…

Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and Clostridioides difficile Infections

Background: Overuse of fluoroquinolones has led to concerning rates of resistance, particularly among Gram-negative organisms. They are also highly implicated as a risk factor for Clostridioides difficile infection, and reports of other serious adverse events led to recommendations to restrict their...

Descripción completa

Detalles Bibliográficos
Autores principales: Wren, Callyn Mariah, Cowper, Jill, Greer, Nickie, Goldin, Laurel, Perry, Alicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598913/
https://www.ncbi.nlm.nih.gov/pubmed/36289969
http://dx.doi.org/10.3390/antibiotics11101312
_version_ 1784816465885528064
author Wren, Callyn Mariah
Cowper, Jill
Greer, Nickie
Goldin, Laurel
Perry, Alicia
author_facet Wren, Callyn Mariah
Cowper, Jill
Greer, Nickie
Goldin, Laurel
Perry, Alicia
author_sort Wren, Callyn Mariah
collection PubMed
description Background: Overuse of fluoroquinolones has led to concerning rates of resistance, particularly among Gram-negative organisms. They are also highly implicated as a risk factor for Clostridioides difficile infection, and reports of other serious adverse events led to recommendations to restrict their use. Our health system began targeting the reduction in unnecessary fluoroquinolone prescribing in 2018, aiming to promote their safe and effective use. Broad-spectrum cephalosporins are often used as an alternative to fluoroquinolones. We sought to evaluate whether decreased fluoroquinolone use was associated with increased third- and fourth-generation cephalosporin use and whether these changes in utilization impacted other outcomes, including C. difficile infection (CDI) rates and susceptibilities among Gram-negative organisms. Methods: This retrospective descriptive analysis included adult patients who received a fluoroquinolone or broad-spectrum cephalosporin in a three-year time period across a large healthcare system. The primary objective was to evaluate the change in days of therapy (DOT) of fluoroquinolones and third- and fourth-generation cephalosporins. Secondary objectives included rates of resistance among common Gram-negative organisms, CDI, and analyses stratified by antibiotic indication. Results: Cephalosporin use increased by an average of 1.70 DOT/1000 PD per month (p < 0.001). Additionally, fluoroquinolone use decreased by an average of 1.18 DOT/1000 PD per month (p < 0.001). C. difficile infections decreased by 0.37 infections/10,000 patient-days per month (p < 0.001). Resistance to fluoroquinolones remained stable from 2018 to 2020, and a declining trend was observed in 2021. Conclusion: This study demonstrated that reduced fluoroquinolone use in a large healthcare system was associated with increased usage of broad-spectrum cephalosporins, decreased CDI and improvements in resistance patterns.
format Online
Article
Text
id pubmed-9598913
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95989132022-10-27 Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and Clostridioides difficile Infections Wren, Callyn Mariah Cowper, Jill Greer, Nickie Goldin, Laurel Perry, Alicia Antibiotics (Basel) Brief Report Background: Overuse of fluoroquinolones has led to concerning rates of resistance, particularly among Gram-negative organisms. They are also highly implicated as a risk factor for Clostridioides difficile infection, and reports of other serious adverse events led to recommendations to restrict their use. Our health system began targeting the reduction in unnecessary fluoroquinolone prescribing in 2018, aiming to promote their safe and effective use. Broad-spectrum cephalosporins are often used as an alternative to fluoroquinolones. We sought to evaluate whether decreased fluoroquinolone use was associated with increased third- and fourth-generation cephalosporin use and whether these changes in utilization impacted other outcomes, including C. difficile infection (CDI) rates and susceptibilities among Gram-negative organisms. Methods: This retrospective descriptive analysis included adult patients who received a fluoroquinolone or broad-spectrum cephalosporin in a three-year time period across a large healthcare system. The primary objective was to evaluate the change in days of therapy (DOT) of fluoroquinolones and third- and fourth-generation cephalosporins. Secondary objectives included rates of resistance among common Gram-negative organisms, CDI, and analyses stratified by antibiotic indication. Results: Cephalosporin use increased by an average of 1.70 DOT/1000 PD per month (p < 0.001). Additionally, fluoroquinolone use decreased by an average of 1.18 DOT/1000 PD per month (p < 0.001). C. difficile infections decreased by 0.37 infections/10,000 patient-days per month (p < 0.001). Resistance to fluoroquinolones remained stable from 2018 to 2020, and a declining trend was observed in 2021. Conclusion: This study demonstrated that reduced fluoroquinolone use in a large healthcare system was associated with increased usage of broad-spectrum cephalosporins, decreased CDI and improvements in resistance patterns. MDPI 2022-09-27 /pmc/articles/PMC9598913/ /pubmed/36289969 http://dx.doi.org/10.3390/antibiotics11101312 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Wren, Callyn Mariah
Cowper, Jill
Greer, Nickie
Goldin, Laurel
Perry, Alicia
Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and Clostridioides difficile Infections
title Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and Clostridioides difficile Infections
title_full Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and Clostridioides difficile Infections
title_fullStr Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and Clostridioides difficile Infections
title_full_unstemmed Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and Clostridioides difficile Infections
title_short Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and Clostridioides difficile Infections
title_sort effect of reduced fluoroquinolone use on cephalosporin use, susceptibilities and clostridioides difficile infections
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598913/
https://www.ncbi.nlm.nih.gov/pubmed/36289969
http://dx.doi.org/10.3390/antibiotics11101312
work_keys_str_mv AT wrencallynmariah effectofreducedfluoroquinoloneuseoncephalosporinusesusceptibilitiesandclostridioidesdifficileinfections
AT cowperjill effectofreducedfluoroquinoloneuseoncephalosporinusesusceptibilitiesandclostridioidesdifficileinfections
AT greernickie effectofreducedfluoroquinoloneuseoncephalosporinusesusceptibilitiesandclostridioidesdifficileinfections
AT goldinlaurel effectofreducedfluoroquinoloneuseoncephalosporinusesusceptibilitiesandclostridioidesdifficileinfections
AT perryalicia effectofreducedfluoroquinoloneuseoncephalosporinusesusceptibilitiesandclostridioidesdifficileinfections